Request Demo
Last update 17 Apr 2026
Jewim Pharmaceutical (Shandong) Co., Ltd
Last update 17 Apr 2026
Overview
Tags
Respiratory Diseases
Nervous System Diseases
Cardiovascular Diseases
Chemical drugs
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20260640
盐酸米安色林片在健康试验参与者中单中心、随机、开放、单剂量、空腹和餐后状态下的生物等效性试验
[Translation] Bioequivalence study of mianserin hydrochloride tablets in healthy participants in a single-center, randomized, open-label, single-dose trial, under fasting and postprandial conditions.
CTR20260268
布地奈德福莫特罗吸入粉雾剂（II）治疗成人哮喘有效性和安全性的多中心、随机、双盲双模拟、阳性药物平行对照临床研究
[Translation] A multicenter, randomized, double-blind, double-dummy, positive-drug parallel-controlled clinical study on the efficacy and safety of budesonide/formoterol inhaled powder (II) in the treatment of adult asthma.
CTR20254751
评价JW2202吸入粉雾剂在慢性阻塞性肺疾病（慢阻肺病）患者中有效性和安全性的多中心、随机、单盲、平行、阳性对照的Ⅲ期临床试验。
[Translation] A multicenter, randomized, single-blind, parallel, positive-controlled phase III clinical trial evaluating the efficacy and safety of JW2202 inhaled powder in patients with chronic obstructive pulmonary disease (COPD).
100 Clinical Results associated with Jewim Pharmaceutical (Shandong) Co., Ltd
Login to view more data
Login to view more data
28 Oct 2024ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES
The crystal structure of (Z)-3′-(2-(1-(3,4-dimethyl-phenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2′-hydroxy-[1,1′-biphenyl]-3-carboxylicacid ─ methanol (1/1), C26H26N4O5
Author: Guo, Xiao ; Cao, Xueli ; Li, Tiejun ; Zhang, Wenhao
Abstract:
C26H26N4O5, triclinic, P1 ‾
27 Aug 2024ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES
The crystal structure of (3aS, 4R, 7S, 7aR)-hexahydro-4, 7-methano-1H-isoindole-1, 3-(2H)-dione, C9H11NO2
Author: Guo, Xiao ; Cao, Xueli
Abstract:
C9H11NO2, monoclinic, P21/c (no. 14), a = 11.293(4) Å, b = 6.998(3) Å, c = 10.932(4) Å, β = 104.175(7)°, V = 837.6(5) Å3, Z = 4, Rgt(F) = 0.0578, wRref(F2) = 0.1330, T = 296 K.
CRYSTENGCOMM
Chiral resolution of dl -leucine via salifying tartaric acid derivatives
Author: Hou, Lingli ; Hao, Hongxun ; De, Ruiyu ; Luo, Xiaofang ; Wang, Ting ; Shi, Linlin ; Zhou, Lina ; Wang, Na ; Wu, Hongchang ; Huang, Xin ; Guo, Zhiqiang
dl-LEU and d-DTTA form diastereomeric salt pairs consisting of d-LEU:d-DTTA:0.5H2O and l-LEU:d-DTTA:0.357CH3OH:0.75H2O.
100 Deals associated with Jewim Pharmaceutical (Shandong) Co., Ltd
Login to view more data
100 Translational Medicine associated with Jewim Pharmaceutical (Shandong) Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Apr 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
1
IND Approval
Phase 1
1
2
Phase 2
Phase 3
1
9
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free